Carmen Reitinger



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy (2024) Beckmann K, Reitinger C, Yan X, Carle A, Blümle E, Jurkschat N, Paulmann C, et al. Journal article Phenotyping of Macrophages in Human Immune System Mice (2024) Voß L, Reitinger C, Lux A Journal article Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment (2023) Haake M, Haack B, Schäfer T, Harter PN, Mattavelli G, Eiring P, Vashist N, et al. Journal article Modulation of urelumab glycosylation separates immune stimulatory activity from organ toxicity (2022) Reitinger C, Ipsen Escobedo A, Hornung C, Heger L, Dudziak D, Lux A, Nimmerjahn F Journal article IN VIVO STUDIES OF IMMUNOMODULATORY A-CTLA-4 ANTIBODY IN A HUMANIZED MOUSE MODEL (2021) Reitinger C, Nimmerjahn F Conference contribution The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies (2021) Monnet C, Jacque E, de Romeuf C, Fontayne A, Abache T, Fournier N, Dupont G, et al. Journal article Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis (2020) Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, Dudziak D, et al. Journal article HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting (2019) Neubert P, Weichselbaum A, Reitinger C, Schatz V, Schröder A, Ferdinand JR, Simon M, et al. Journal article